Levocetirizine, Phenylephrine & Ambroxol Tablets

Feb 11, 2023

Sterimmune Cold
Levocetirizine, Phenylephrine & Ambroxol Tablet is used to treat common cold symptoms. It thins mucus in the nose, windpipe and lungs making it easier to cough out. It also provides relief from seasonal allergic conditions such as runny nose, watery eyes, sneezing and congestion or stuffiness.
Levocetirizine, Phenylephrine & Ambroxol Tablets should be taken with food. For better results, it is suggested to take it at the same time every day. The dose and how often you take it depend on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. It is advised not to use it for more than 14 days without your doctor's consultation.
The most common side effects of this medicine include vomiting, nausea, and stomach upset. Talk to your doctor if you are worried about side effects or they would not go away. Generally, it is advised not to take alcohol while on treatment.
Before taking this medicine, tell your doctor if you have liver or kidney disease or if you have stomach problems. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. You must take a doctor's advice before using this medicine if you are pregnant or breastfeeding.

Steris Healthcare Pvt Ltd is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week We have New product in our Portfolio. In Last 4 years we are Dealing in Chronic Theraphy and in 4 years we Grow by 200% Annually, because We Deal in High Quality Medicine. Steris Medicine manufacture at WHO-GMP Approved Plants & We have Legal manufacturing contract with all leading Manufacturer of Inda. Today we have 1000+ Business Franchise Partner in PAN India. Steris's Medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with the similar pace with the STERIS. Be first to launch like us.

SHARE WITH